About Exelixis, Inc.

Exelixis, Inc. (NASDAQ: EXEL) is a Healthcare company (Biotechnology) with a market capitalization of $16.3B. Its Maz Rating is 4.94 out of 5 (A, Strong Buy), ranked against the other companies in its sector.

Factor scores: Valuation 2.32, Growth 3.96, Profitability 4.99, Financial Health 4.67, Momentum 4.40 (as of 2026-10-16).

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

CEO

Michael Morrissey

Employees

1,077

IPO date

2000-04-17